[1]
Kogge, A. et al. 2014. Vorinostat for Refractory or Relapsing Epidermotropic T-cell Lymphoma: A Retrospective Cohort Study of 15 Patients. Acta Dermato-Venereologica. 95, 1 (May 2014), 72–77. DOI:https://doi.org/10.2340/00015555-1886.